Focused Wealth Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Focused Wealth Management’s Portfolio NDRM Stock Details NDRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-32	Closed	-$1K	–	782
2018 Q1	$1K	Hold	32	–	–	﹤0.01%	685
2017 Q4	$1K	Buy	+32	New	+$1.25K	﹤0.01%	670
2017 Q3	–	Sell	-32	Closed	-$1K	–	786
2017 Q2	$1K	Hold	32	–	–	﹤0.01%	693
2017 Q1	$1K	Hold	32	–	–	﹤0.01%	681
2016 Q4	$1K	Sell	32 -43	-57%	-$804	﹤0.01%	680
2016 Q3	$1K	Hold	75	–	–	﹤0.01%	656
2016 Q2	$1K	Hold	75	–	–	﹤0.01%	658
2016 Q1	$1K	Sell	75 -1,500	-95%	-$20.3K	﹤0.01%	643
2015 Q4	$27K	Buy	+1,575	New	+$30.7K	0.02%	288

Focused Wealth Management's NDRM Position: Q2 2018 in Review

Focused Wealth Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q2 2018, closing a stake of 32 shares — an estimated $1K sold.

Focused Wealth Management first reported a position in NDRM in Q4 2015 and held it in 9 quarters. The position peaked at $27K in Q4 2015. 0 funds tracked by Wall St. Rank hold NDRM as of Q2 2018.

Focused Wealth Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q2 2018 after selling out during the quarter.
Focused Wealth Management sold 32 NeuroDerm Ltd. Ordinary Shares shares in Q2 2018, an estimated $1K.
Focused Wealth Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2015 and held it in 9 quarters.
Focused Wealth Management's NeuroDerm Ltd. Ordinary Shares position peaked at $27K in Q4 2015.
0 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q2 2018.

Based on Focused Wealth Management's 13F filing for Q2 2018, filed 15 Aug 2018.